Abbott launches new point-of-care test for HIV management

 In the Netherlands, Abbott has introduced the m-PIMA HIV-1/2 VL poc hiv for the quick, accurate, and simple management of HIV infection.

The new method, which is said to be the first test for measuring viral load at the point of care, gives results in 70 minutes and allows for screening and treatment in one visit.

Viral load testing is regarded as the standard for monitoring ART treatment failure. If an individual is stable on ART, the World Health Organization (WHO) recommends that they undergo a viral load test every six months, every 12 months, and every year after that.

"The new technique, which is said to be the first test for measuring viral load at the point of care, delivers results in 70 minutes and makes it possible to screen and treat in one visit."

For more insights on the poc hiv, Download a Free Sample

Damian Halloran, vice president of Abbott Rapid Diagnostics for Emerging Markets for Infectious Diseases, stated: Abbott is committed to providing HIV diagnostic solutions that enable life-saving decisions that have a significant impact on people and society and support the UNAIDS agenda.

"The m-PIMA HIV-1/2 VL is an illustration of Abbott's commitment to providing tools that empower healthcare providers and patients wherever and whenever they are most needed,"

The addition of m-PIMA HIV-1/2 VL to the company's portfolio of HIV care diagnostic solutions spans more than 120 nations, including all 55 African nations.

The purpose of the quantitative nucleic acid amplification test is to determine the viral load of HIV-2 and HIV-1 groups M/N and O in plasma samples.

It supports decentralized program management by facilitating data point connectivity on the portable m-PIMA platform.

A quantitative assay called RealTime HIV-1, developed to identify HIV-1 virus in infected blood spots or plasma samples, is also part of Abbott's HIV portfolio.

The purpose of the in-vitro reverse transcription polymerase chain reaction (RT-PCR) assay is to provide improved monitoring precision.

Comments